Last reviewed · How we verify

NCT04056286

Gastro-intestinal and Hormonal Responses to Systemic Inflammatory Disease

Completed NA Last updated 11 June 2020
What this trial tests

NA trial testing Whey in Motility Disorder in 8 participants. Completed in 23 January 2020.

Timeline
17 June 2019
Primary endpoint
23 January 2020
23 January 2020

Quick facts

Lead sponsorUniversity of Aarhus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment8
Start date17 June 2019
Primary completion23 January 2020
Estimated completion23 January 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

Adults 20 to 40, male only, with Motility Disorder or Catabolic State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to describe hormonal responses and changes of the gastrointestinal (GI) tract during healthy and catabolic inflammatory conditions. Participants will receive isocaloric, isonitrogenous beverages of either whey or 3-OHB+whey in a randomized crossover design during either healthy (overnight fast) or catabolic conditions (inflammation/endotoxemia + 36 h fast and bed rest).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Whey

Trials testing the same drug.

Other recruiting trials for Motility Disorder

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04056286.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing